NEW YORK (TheStreet) -- Allergan (AGN) soared in after-hours trading on Monday amid news that activist investor William Ackman and Valeant Pharmaceuticals International have joined forces to pursue a takeover of the health care company.
Ackman is the founder and CEO of hedge fund Pershing Square Capital Management, which has built an almost 10% stake in Allergan, according to CNBC. The company is worth approximately $4 billion.
Allergan closed at $142, an all-time high, and then surged 19% after the market closed. More than 9 million shares changed hands, more than triple the average volume of 2,944,310.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts